Credit Suisse Ag Chimerix Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Chimerix Inc stock. As of the latest transaction made, Credit Suisse Ag holds 94,000 shares of CMRX stock, worth $91,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,000

Previous 134,000 29.85%

Holding current value

$91,180

Previous $128,000 22.66%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.91 - $1.26 $36,400 - $50,400	-40,000 Reduced 29.85%	94,000 $99,000
Q4 2023 Feb 08, 2024	SELL	$0.9 - $1.06 $58,680 - $69,112	-65,200 Reduced 32.73%	134,000 $128,000
Q3 2023 Nov 13, 2023	SELL	$0.94 - $1.23 $305,312 - $399,504	-324,800 Reduced 61.98%	199,200 $191,000
Q1 2023 May 10, 2023	SELL	$1.19 - $2.09 $3 - $6	-3 Reduced -0.0%	524,000 $660,000
Q4 2022 Feb 13, 2023	SELL	$1.67 - $2.35 $162,835 - $229,139	-97,506 Reduced 15.69%	524,003 $974,000
Q3 2022 Nov 10, 2022	BUY	$1.81 - $2.76 $543,897 - $829,368	300,496 Added 93.61%	621,509 $1.2 Million
Q2 2022 Aug 12, 2022	BUY	$1.34 - $5.34 $7,834 - $31,222	5,847 Added 1.86%	321,013 $667,000
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $341,599 - $507,178	74,585 Added 31.0%	315,166 $1.44 Million
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $1.02 Million - $1.39 Million	194,207 Added 418.78%	240,581 $1.55 Million
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $21,770 - $32,068	3,665 Added 8.58%	46,374 $288,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $322,025 - $418,121	42,709 New	42,709 $341,000
Q1 2021 May 14, 2021	SELL	$4.76 - $11.25 $93,162 - $220,185	-19,572 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.43 - $5.42 $47,559 - $106,080	19,572 New	19,572 $95,000
Q4 2019 Feb 12, 2020	SELL	$1.3 - $2.72 $218,277 - $456,704	-167,906 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$1.93 - $4.21 $324,058 - $706,884	167,906 New	167,906 $394,000
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $23,369 - $49,248	-11,400 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.79 - $3.12 $20,406 - $35,568	11,400 New	11,400 $24,000
Q3 2018 Nov 13, 2018	SELL	$3.58 - $4.9 $55,343 - $75,749	-15,459 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$4.43 - $5.14 $16,563 - $19,218	-3,739 Reduced 19.48%	15,459 $74,000
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $6,128 - $7,776	1,318 Added 7.37%	19,198 $100,000
Q4 2017 Feb 14, 2018	SELL	$4.32 - $5.52 $212,738 - $271,832	-49,245 Reduced 73.36%	17,880 $83,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $210,352 - $253,874	48,357 Added 257.66%	67,125 $352,000
Q2 2017 Aug 14, 2017	BUY	N/A	18,768	18,768 $102,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account